Sp856
PANEL DISCUSSION: INNOVATIONS IN HOW WE TREAT, DISSEMINATE, AND TEACH
Date
May 20, 2024
Presenters
Mayo Clinic
Michael E. DeBakey VAMC
Tracks
Related Products
SERUM BIOMARKER SIGNATURE IS PREDICTIVE OF THE RISK OF HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS
BACKGROUND. Several inflammatory and metabolic biomarkers have been associated with hepatocellular carcinoma (HCC) risk in phase I and II biomarker studies but not in longitudinal studies…
MULTIOMIC CHARACTERIZATION OF GASTRIC MUSCULARIS PROPRIA IN IDIOPATHIC GASTROPARESIS
BACKGROUND: Idiopathic gastroparesis (IG) is an increasingly prevalent subtype of gastroparesis and causes significant morbidity and decreased quality of life…
SINGLE USE ENDOSCOPES: THE FUTURE IS NOW
This session will highlight the current state of the art around innovation in endoscopy as it pertains to climate, the environment, and the endoscopist…
